GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0042221 |
response to chemical
|
ABCG2, ADRA1A, ADRA2A, AKR1B1, ALPL, AXL, BCL2, CA2, CDK6, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, HMGCR, HSD11B2, HSD17B2, HSPA1A, HTR2A, HTR2B, HTR5A, IGF1R, INSR, KCNH2, KDR, MMP2, MMP9, PPARA, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TOP1, TYR |
13.8262 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCG2, ACHE, ADORA1, ADRA1A, ADRA2A, AKR1B1, AURKB, AXL, BCL2, CA12, CA2, CA7, CDK6, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, EGFR, ESR1, F10, F3, FABP3, FABP4, FLT3, GPR35, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR2A, HTR2B, HTR7, INSR, KCNH2, KDR, MET, PPARA, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
13.7421 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, F3, FABP3, FLT3, HMGCR, HSPA1A, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, NUAK1, PIM1, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
13.016 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F10, F3, FLT3, GPR35, HMGCR, HSPA1A, HTR2A, HTR2B, HTR6, INSR, KDR, MET, MMP12, MMP9, PTPN1, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
13.016 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F10, F3, FLT3, GPR35, HMGCR, HSPA1A, HTR2A, HTR2B, HTR6, INSR, KDR, MET, MMP12, MMP9, PTPN1, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
13.016 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CES1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, ESR1, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
11.5531 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, F10, F3, FLT3, GPR35, HMGCR, HSPA1A, HTR2A, HTR2B, HTR6, INSR, KDR, MET, MMP12, MMP9, PTPN1, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
10.884 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, AKR1B10, ALOX5, ALPL, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESRRB, F10, F3, FABP4, HMGCR, HSD11B2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR7, IGF1R, INSR, KCNH2, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TNKS2, TOP1, TYR |
10.7072 |
[BP] GO:0010033 |
response to organic substance
|
ADRA1A, ADRA2A, AKR1B1, ALPL, AXL, BCL2, CA2, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, HMGCR, HSD11B2, HSD17B2, HSPA1A, HTR5A, IGF1R, INSR, KDR, MMP2, PPARA, RORC, SLC6A4, SMAD3, SRC, TEK, TYR |
10.6841 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA1A, ADRA2A, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FLT3, GPR35, HMGCR, HSPA1A, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
10.5109 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, AXL, BCL2, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, ESR1, ESRRA, FABP3, HMGCR, HSD11B2, HSD17B2, HTR5A, IGF1R, INSR, MMP2, MMP9, PPARA, RORC, SLC6A4, SRC, TEK, TYR |
10.4296 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DRD2, EGFR, ESR1, FABP3, FABP4, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET, PPARA |
10.3036 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, DRD2, DRD3, EGFR, ESR1, F3, FLT3, HMGCR, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, PIM1, TEK, TERT |
9.97593 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA1A, ADRA2A, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, F3, FLT3, GPR35, HMGCR, HSPA1A, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PTPN1, SLC6A4, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
9.92707 |
[BP] GO:0042493 |
response to drug
|
ABCG2, ADRA1A, AKR1B1, AXL, BCL2, CDK6, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, FABP3, HMGCR, HSD11B2, HTR2A, HTR2B, KCNH2, KDR, SLC6A2, SLC6A4, SRC, TOP1 |
9.87232 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA1A, ADRA2A, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, F3, FLT3, GPR35, HMGCR, HSPA1A, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PTPN1, SLC6A4, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
9.77202 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, EGFR, HMGCR, HTR1A, HTR2A, HTR2B, HTR7, SLC6A4, SRC, TEK |
9.68649 |
[BP] GO:0050896 |
response to stimulus
|
ABCG2, ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, ALPL, AURKB, AXL, BCL2, CA2, CDK6, CES1, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, ESR1, ESRRA, F10, F3, FABP3, FABP4, FLT3, HMGCR, HSD11B2, HSD17B2, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, IGF1R, INSR, KCNH2, KDR, MMP12, MMP2, MMP9, NUAK1, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TOP1, TYR |
9.46369 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, AXL, BCL2, CYP1B1, DRD2, EGFR, F10, F3, FLT3, GPR35, HMGCR, HSPA1A, HTR2A, HTR2B, HTR6, INSR, KDR, MET, PTPN1, SRC, TEK, XDH |
9.1663 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ESRRA, F10, F3, FABP4, FLT3, GPR35, HMGCR, HSPA1A, HTR2A, HTR2B, HTR6, INSR, KDR, MET, MMP12, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
9.14252 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA1A, ADRA2A, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GPR35, HMGCR, HSPA1A, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
9.13048 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DUSP3, EGFR, ESR1, F10, F3, FLT3, GPR35, HMGCR, HSPA1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPN1, SRC, TEK, XDH |
9.13048 |
[BP] GO:0008152 |
metabolic process
|
ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR2B, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
8.89929 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADRA2A, AURKB, BCL2, CA2, CA7, CDK6, DRD1, DRD2, DRD3, EGFR, HMGCR, HTR2A, HTR2B, KDR, SRC, TNKS, TNKS2 |
8.60355 |
[BP] GO:0097756 |
None
|
ADORA1, ADRA1A, HMGCR, HTR1A, HTR2A, HTR2B, HTR7, SLC6A4 |
8.33988 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA1A, ADRA2A, AKR1B1, ALPL, BCL2, CA2, CSNK2A1, CYP1A2, DRD1, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HTR5A, IGF1R, INSR, MMP2, PPARA, SLC6A4, SMAD3, SRC, TEK |
8.33327 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, ESR1, ESRRA, FLT3, HSD11B2, HTR5A, RORC, SLC6A4, SRC, TEK, TYR |
8.29958 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, EGFR, HMGCR, HTR1A, HTR2A, HTR2B, HTR7, SLC6A4, SRC, TEK |
8.29572 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, EGFR, HMGCR, HTR1A, HTR2A, HTR2B, HTR7, SLC6A4 |
8.25337 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, EGFR, HMGCR, HTR1A, HTR2A, HTR2B, HTR7, SLC6A4 |
8.25337 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ADRA2A, AXL, BCL2, CA2, CA7, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F10, F3, GPR35, HMGCR, HSPA1A, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KCNH2, KDR, MET, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SMAD3, SRC, TEK, TERT |
8.21923 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADRA2A, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, EGFR, ESR1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2A |
8.20421 |
[BP] GO:0009725 |
response to hormone
|
ADRA1A, ADRA2A, AKR1B1, ALPL, BCL2, CA2, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HTR5A, INSR, PPARA, SLC6A4, SRC, TEK |
8.20421 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, EGFR, HMGCR, HTR1A, HTR2A, HTR2B, HTR7, SLC6A4 |
8.00625 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, EGFR, HMGCR, HTR1A, HTR2A, HTR2B, HTR7, SLC6A4 |
7.9799 |
[BP] GO:0042592 |
homeostatic process
|
ABCG2, ADORA1, ADRA1A, ADRA2A, AKR1B1, AXL, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, HTR2A, HTR2B, INSR, KCNH2, MET, SMAD3, SRC, TERT |
7.83156 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALPL, AURKB, AXL, BCL2, CA2, CDC25B, CDK6, CES1, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, HMGCR, HSD11B1, HSD17B2, HTR2A, HTR2B, HTR5A, INSR, KDR, MET, MMP2, MMP9, PIM1, PPARA, RORC, SIGMAR1, SLC6A4, SMAD3, SRC, TEK, TERT, TNKS2, TYR |
7.68507 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA1A, ADRA2A, BCL2, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, GPR35, HMGCR, HSPA1A, HTR2A, IGF1R, MET, MMP12, MMP9, PTPN1, SLC6A4, SMAD3, SRC, TERT, XDH |
7.64055 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ADRA2A, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TERT |
7.6393 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA1A, ADRA2A, BCL2, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, GPR35, HMGCR, HSPA1A, HTR2A, IGF1R, MET, MMP12, MMP9, PTPN1, SLC6A4, SMAD3, SRC, TERT, XDH |
7.62758 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CDK6, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, HTR5A, RORC, SLC6A4, SRC, TYR |
7.60539 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TYR |
7.54829 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, AURKB, BCL2, CA2, CYP1A1, DRD1, DRD2, DRD3, EGFR, HMGCR, HSD11B2, HSPA1A, HTR2A, HTR2B, MMP2, PPARA, SLC6A4, SMAD3, SRC, TEK, TERT, TYR |
7.51008 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ADRA2A, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TERT |
7.47222 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, F10, F3, FABP4, FLT3, GPR35, HMGCR, HSPA1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP12, MMP2, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
7.41722 |
[BP] GO:0048878 |
chemical homeostasis
|
ABCG2, ADRA1A, ADRA2A, AKR1B1, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, EGFR, ESR1, FABP3, FABP4, GPR35, HTR2A, HTR2B, INSR, KCNH2, MET, SMAD3 |
7.21387 |
[BP] GO:0044237 |
cellular metabolic process
|
ABCG2, ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GBA2, HMGCR, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR2B, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP2, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
7.14735 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ADRA2A, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TERT |
7.14552 |
[BP] GO:0044281 |
small molecule metabolic process
|
ABCG2, AKR1B1, AKR1B10, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, FABP3, FUT7, GBA2, HMGCR, HSPA1A, HTR2B, PIM1, PPARA, TYR, XDH |
7.12114 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, F3, FLT3, GPR35, HMGCR, HSPA1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
6.99642 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ADRA2A, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TERT |
6.89187 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, HMGCR, HSPA1A, HTR2A, HTR2B, IGF1R, KCNH2, KDR, MET, MMP12, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
6.84246 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, DRD3, EGFR, ESR1, HTR7, PPARA, RORC, SLC6A4, SRC, TOP1 |
6.80405 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, BCL2, CES1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, GBA2, HMGCR, HTR1A, TYR |
6.78045 |
[BP] GO:0007187 |
None
|
ADORA1, ADRA1A, ADRA2A, CHRM2, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR6, HTR7 |
6.68423 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.6504 |
[BP] GO:0007210 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.59899 |
[BP] GO:0098664 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.59899 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, EGFR, FLT3, HTR2B, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIM1, SRC, TEK, TNKS, TOP1 |
6.59899 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA1A, ADRA2A, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HMGCR, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
6.58041 |
[BP] GO:0032845 |
None
|
ADORA1, ADRA2A, BCL2, DRD2, HMGCR, HTR2A, HTR2B, SRC, TNKS, TNKS2 |
6.5595 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA1A, ADRA2A, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HMGCR, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
6.50647 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, HMGCR, HSPA1A, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK, TERT |
6.50574 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, ALPL, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MMP2, MMP9, RORC, SLC6A4, SMAD3, SRC, TERT |
6.50574 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA1A, ADRA2A, BCL2, CDK6, CYP19A1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, HMGCR, HSPA1A, IGF1R, MET, MMP12, MMP9, PPARA, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
6.50444 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, BCL2, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TERT |
6.49035 |
[BP] GO:0071704 |
organic substance metabolic process
|
ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR2B, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
6.49035 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA1A, ADRA2A, BCL2, CDC25B, DRD1, DRD2, DRD3, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, HMGCR, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
6.44201 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CES1, CES2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DRD2, EGFR, FABP3, FABP4, FUT7, GBA2, HMGCR, MET, PPARA |
6.43039 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ABCG2, ACHE, AKR1B1, ALPL, AOX1, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, F10, F3, FLT3, FUT7, GBA2, HMGCR, HSPA1A, HTR1A, HTR2B, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1, TYR, XDH |
6.43039 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, HMGCR, HSPA1A, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SMAD3, SRC, TEK, TERT |
6.43039 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, ADRA2A, BCL2, CDC25B, DRD1, DRD2, DRD3, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, HMGCR, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
6.38668 |
[BP] GO:0007193 |
None
|
ADORA1, ADRA2A, CHRM2, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
6.35992 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HMGCR, HSPA1A, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SIGMAR1, SMAD3, SRC, TEK, TERT, XDH |
6.35273 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA1A, ADRA2A, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HMGCR, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
6.35273 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HMGCR, HSPA1A, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SIGMAR1, SMAD3, SRC, TEK, TERT, XDH |
6.35273 |
[BP] GO:0048513 |
animal organ development
|
ACHE, ADRA1A, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, INSR, KDR, PPARA, SMAD3, SRC, TEK, TYR |
6.34435 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, SLC6A4, SMAD3, SRC, TEK, TERT |
6.34435 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ADRA2A, BCL2, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TERT |
6.34435 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA1A, ADRA2A, CHRM2, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
6.32122 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, RORC |
6.30383 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AXL, BCL2, CA2, CDK6, CHRM2, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, ESRRB, F3, GPR35, HMGCR, HSPA1A, HTR2A, HTR2B, INSR, KCNH2, KDR, MET, MMP12, MMP9, PIM1, SLC6A4, SMAD3, SRC, TEK, TERT, TNKS2, XDH |
6.28848 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HMGCR, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, TERT, TNKS, XDH |
6.28833 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, HTR2B, KDR, SRC |
6.27782 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, ADRA2A, BCL2, CDC25B, DRD1, DRD2, EGFR, ESRRB, FABP3, FLT3, HMGCR, HTR2A, HTR2B, INSR, KDR, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
6.23783 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA1A, ADRA2A, BCL2, CDC25B, DRD1, DRD2, EGFR, ESRRB, FABP3, FLT3, HMGCR, HTR2A, HTR2B, INSR, KDR, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
6.23783 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, SLC6A4, SMAD3, SRC, TEK, TERT |
6.23502 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, EGFR, F10, F3, INSR, MET, SRC, TEK, XDH |
6.23197 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ADRA2A, BCL2, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TERT |
6.22656 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, AXL, BCL2, CA1, CA2, CDK6, CHRM2, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KCNH2, KDR, MET, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SIGMAR1, SMAD3, SRC, TEK, TNKS, TNKS2 |
6.22567 |
[BP] GO:0042310 |
None
|
ADRA1A, HTR1A, HTR2A, HTR2B, HTR7, SLC6A4 |
6.22118 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA1A, ADRA2A, AURKB, BCL2, CDC25B, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HMGCR, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
6.19715 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CES1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, HMGCR, KDR, SLC6A4, SRC |
6.18528 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F3, FABP4, FLT3, GPR35, HMGCR, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, MET, MMP9, NUAK1, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK, TERT, TNKS, XDH |
6.17231 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALPL, AXL, BCL2, CA2, CDK6, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FLT3, GBA2, HSD11B1, HSD17B2, HTR5A, INSR, KDR, MMP9, PIM1, PPARA, RORC, SIGMAR1, SMAD3, SRC, TEK, TYR |
6.13187 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, FLT3, HMGCR, HSPA1A, HTR2B, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIM1, PTPN1, SRC, TEK, TNKS, TOP1, XDH |
6.05777 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ADRA2A, BCL2, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TERT |
6.05096 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, EGFR, HMGCR |
6.02658 |
[BP] GO:0007200 |
None
|
ADRA1A, ADRA2A, CHRM2, DRD1, DRD2, ESR1, HTR2A, HTR2B |
6.00569 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CES1, CYP19A1, CYP3A4, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.00273 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP2C19, CYP2D6, CYP3A4 |
6.00186 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ADRA2A, AXL, BCL2, CA2, CA7, CYP19A1, DRD1, DRD2, DRD3, EGFR, GPR35, HMGCR, HSPA1A, HTR1A, HTR2A, HTR2B, INSR, KCNH2, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SMAD3, SRC, TERT |
5.95588 |
[BP] GO:0050801 |
ion homeostasis
|
ABCG2, ADRA1A, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, EGFR, ESR1, FABP3, GPR35, HTR2A, HTR2B, KCNH2, SMAD3 |
5.90398 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, HMGCR, HSPA1A, HTR2B, IGF1R, KDR, MMP9, PIM1, PTPN1, SMAD3, SRC, TEK, TERT |
5.89117 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, SLC6A4, SMAD3, SRC, TEK, TERT |
5.88837 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HMGCR, HSPA1A, HTR2B, IGF1R, KDR, MMP9, PIM1, PTPN1, SIGMAR1, SMAD3, SRC, TEK, TERT, XDH |
5.87598 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR2B, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
5.83337 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA1A, ADRA2A, DRD2, EGFR, FLT3, HMGCR, HTR2A, HTR2B, INSR, KDR, PTPN1, SRC, TEK, XDH |
5.82535 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, ADRA2A, CYP1A1, DRD3, FABP3, FLT3, HMGCR, HTR2A, HTR2B, PPARA, RORC, SRC, TEK |
5.81171 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
5.75664 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, FLT3, HMGCR, HSPA1A, HTR2B, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIM1, PTPN1, SRC, TEK, TNKS, TOP1, XDH |
5.67171 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, EGFR, HSPA1A |
5.65724 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, HMGCR, HSPA1A, HTR2A, HTR2B, IGF1R, KCNH2, KDR, MET, MMP12, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
5.65024 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, ADRA2A, BCL2, DRD2, DRD3, GPR35, HTR2A, KCNH2, MMP9 |
5.62968 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK |
5.51533 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP4, KDR, MMP9, SRC, TERT |
5.51435 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA1A, ADRA2A, DRD2, DUSP3, EGFR, FLT3, HMGCR, HTR2A, HTR2B, IGF1R, INSR, KDR, PTPN1, SRC, TEK, XDH |
5.50744 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, DRD3, EGFR, HTR1A, INSR, SLC6A2, SLC6A4, SMAD3 |
5.49754 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, ADRA2A, CDK6, CYP19A1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, HMGCR, HSPA1A, IGF1R, MET, MMP12, MMP2, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
5.49166 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
ABCG2, ADRA1A, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, EGFR, ESR1, GPR35, HTR2A, HTR2B, KCNH2, SMAD3 |
5.38535 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, EGFR |
5.37656 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2 |
5.3475 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, EGFR, FLT3, HTR2B, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIM1, SRC, TEK, TNKS, TOP1 |
5.29865 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA1A, ADRA2A, BCL2, CDC25B, DRD1, DRD2, DUSP3, EGFR, ESRRB, FABP4, FLT3, HMGCR, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP9, PPARA, PTPN1, SRC, TEK, XDH |
5.27635 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, SRC, TEK |
5.26893 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, ADRA2A, AURKB, CSNK2A1, CYP1B1, CYP2D6, DRD2, DRD3, DUSP3, ESR1, FABP4, GPR35, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TNKS |
5.22215 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, ADRA2A, DUSP3, EGFR, FLT3, HMGCR, HTR2A, HTR2B, IGF1R, INSR, PTPN1, SRC |
5.22215 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.21481 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ADRA1A, DRD2, DUSP3, EGFR, HMGCR, HTR2A, HTR2B, KDR, PTPN1, SRC, TEK |
5.21334 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, ADRA2A, AXL, BCL2, CA2, CYP19A1, DRD1, DRD2, DRD3, EGFR, HTR2B, INSR, KCNH2, MMP12, SLC6A4, SMAD3, SRC, TERT |
5.1526 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA1A, ADRA2A, AXL, BCL2, CA2, CYP1B1, DRD2, DRD3, EGFR, ESRRB, F3, HMGCR, HSPA1A, HTR2A, HTR2B, KDR, MET, MMP12, MMP9, PIM1, SMAD3, SRC, TEK, TERT |
5.13238 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2, DRD3, HTR1A, TYR |
5.07721 |
[BP] GO:0006939 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
4.99533 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA1A, ADRA2A, BCL2, CDC25B, DRD2, EGFR, ESRRB, FLT3, HMGCR, HTR2A, HTR2B, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH |
4.98413 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
4.98256 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
ADRA1A, BCL2, DRD2, DRD3, DUSP3, ESR1, HMGCR, HSPA1A, IGF1R, MET, MMP9, PTPN1, SRC, XDH |
4.97253 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, ALPL, AXL, BCL2, CDK6, CYP1A1, CYP1B1, DRD1, EGFR, ESR1, FABP4, FLT3, IGF1R, INSR, KDR, MMP2, RORC, SLC6A4, SMAD3, SRC |
4.94651 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
4.9282 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, EGFR, HTR2A, SLC6A4 |
4.8395 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, EGFR, HTR2A, SLC6A4 |
4.8395 |
[BP] GO:0055080 |
cation homeostasis
|
ABCG2, ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, EGFR, ESR1, GPR35, HTR2A, HTR2B, KCNH2, SMAD3 |
4.76677 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA1A, ADRA2A, AURKB, BCL2, CDC25B, DRD2, EGFR, ESR1, ESR2, F3, FLT3, HSPA1A, HTR2A, HTR2B, INSR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, TERT, TNKS, XDH |
4.75395 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA1A, ADRA2A, BCL2, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, HMGCR, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH |
4.70951 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
4.69761 |
[BP] GO:0003008 |
None
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, BCL2, CYP1B1, DRD1, DRD2, DRD3, EGFR, HMGCR, HSD11B2, HTR1A, HTR2A, HTR2B, HTR7, INSR, KCNH2, SLC6A4, SRC, TEK, TYR |
4.67834 |
[BP] GO:0007623 |
circadian rhythm
|
DRD2, DRD3, EGFR, HTR7, PPARA, RORC, SLC6A4, TOP1 |
4.65189 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
4.6476 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA1A, ADRA2A, BCL2, CDC25B, DRD2, EGFR, FLT3, HMGCR, HTR2A, HTR2B, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH |
4.60846 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA1A, ADRA2A, AURKB, BCL2, CDC25B, DRD2, EGFR, ESR1, F3, FLT3, HSPA1A, HTR2A, HTR2B, INSR, PTPN1, SMAD3, SRC, TEK, TERT, TNKS, XDH |
4.51208 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ADRA1A, DRD2, EGFR, HMGCR, HTR2A, HTR2B, KDR, SRC, TEK |
4.51208 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA1A, ADRA2A, BCL2, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, HMGCR, HSPA1A, IGF1R, MET, MMP12, MMP9, PTPN1, SMAD3, SRC, TERT, XDH |
4.51208 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6 |
4.49812 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, DRD1, DRD2, DRD3, EGFR, FABP3, FLT3, HSD11B2, IGF1R, INSR, MMP2, PPARA, SLC6A4, SRC, TEK, TYR |
4.49316 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, ADRA1A, CA2, CA7, DRD2 |
4.46687 |
[BP] GO:0007198 |
None
|
HTR1A, HTR5A, HTR7 |
4.41447 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.41447 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
ADRA1A, EGFR, ESR1, HTR2A, HTR2B |
4.40341 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, FABP3, FABP4, FUT7, GBA2, HSPA1A, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
4.38904 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, DRD3, EGFR, ESR1, F3, FABP4, HMGCR, KDR, MET, MMP12, PPARA, SMAD3, TEK |
4.33735 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2, HTR2A, SLC6A4 |
4.3332 |
[BP] GO:0050795 |
None
|
ADORA1, DRD2, DRD3, HTR1A, HTR2A, HTR2B |
4.3332 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, F10, F3, INSR, MET, SRC, TEK |
4.33047 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6 |
4.31994 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, EGFR, HTR6 |
4.29098 |
[BP] GO:1900274 |
regulation of phospholipase C activity
|
ADRA1A, EGFR, ESR1, HTR2A, HTR2B |
4.23356 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7 |
4.23356 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, ADRA2A, AURKB, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, HMGCR, HTR2A, HTR2B, IGF1R, INSR, PTPN1, SRC, TEK, TNKS |
4.2183 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, ADRA2A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, GPR35, HTR1A, HTR2A, KCNH2, MMP9, SLC6A4 |
4.2183 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, HTR2A, INSR, MET, SMAD3, SRC |
4.2183 |
[BP] GO:0009987 |
cellular process
|
ABCG2, ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CDK6, CES1, CES2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GPR35, HMGCR, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SIGMAR1, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
4.20609 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA1A, ADRA2A, BCL2, CDC25B, CSNK2A1, DRD2, EGFR, ESR1, F3, FLT3, HMGCR, HSPA1A, HTR2A, HTR2B, INSR, KDR, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
4.20384 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, DRD3, SLC6A4 |
4.16985 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADRA1A, ADRA2A, BCL2, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, HMGCR, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP9, NUAK1, PTPN1, SRC, TEK, XDH |
4.11628 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, DRD1, DRD2, DRD3, EGFR, FABP3, FLT3, HSD11B2, IGF1R, INSR, MMP2, PPARA, SLC6A4, SRC, TEK, TYR |
4.09906 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, ALPL, AURKB, AXL, BCL2, CA2, CDK6, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MMP2, MMP9, NUAK1, PTPN1, RORC, SLC6A4, SMAD3, SRC, TERT |
4.07479 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, DRD3, EGFR, TNKS, TNKS2 |
4.07039 |
[BP] GO:0090066 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, EGFR, HMGCR, HTR1A, HTR2A, HTR2B, HTR7, SLC6A4 |
4.0639 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, SRC, TEK |
4.06204 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA1A, ADRA2A, AKR1B1, AXL, BCL2, CYP1B1, DRD1, DRD2, DRD3, EGFR, HTR2A, HTR2B, HTR5A, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PTPN1, SRC, TEK |
4.04839 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, FABP3, PPARA |
4.04839 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
AURKB, CDC25B, CYP1A1, DRD2, DRD3, DUSP3, EGFR, INSR, SLC6A4, SRC, TERT |
4.04839 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA1A, ADRA2A, BCL2, CDC25B, DRD2, EGFR, ESR1, F3, FLT3, HMGCR, HSPA1A, HTR2A, HTR2B, INSR, KDR, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
4.03477 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, ADRA1A, ADRA2A, CA2, CHRM2, DRD1, DRD2, DRD3, ESR1, GPR35, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, INSR, SIGMAR1, SRC |
4.00862 |
[BP] GO:0055065 |
metal ion homeostasis
|
ABCG2, ADRA1A, BCL2, DRD1, DRD2, DRD3, EGFR, ESR1, GPR35, HTR2A, HTR2B, KCNH2, SMAD3 |
4.00519 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
AURKB, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MMP12, PPARA, RORC, SMAD3, SRC, TERT, TNKS, TNKS2 |
3.97327 |
[BP] GO:0065007 |
biological regulation
|
ABCG2, ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CDC25B, CDK6, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GPR35, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SIGMAR1, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP1, XDH |
3.96783 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
ADRA1A, ADRA2A, DRD1, DRD2, DRD3, EGFR, HTR2B, HTR5A, KDR |
3.95336 |
[BP] GO:0051952 |
None
|
ADORA1, ADRA2A, DRD1, DRD2, DRD3, HTR2A |
3.94614 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, HMGCR, MMP2, MMP9, TERT |
3.94614 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, ADRA2A, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, HMGCR, HTR2A, HTR2B, IGF1R, INSR, PTPN1, SRC, TEK |
3.94148 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2, EGFR |
3.93396 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, RORC, SRC |
3.93067 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, PPARA, SRC, TEK |
3.89126 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, BCL2, CYP1A1, DRD2, EGFR, PPARA, SMAD3 |
3.86216 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
AURKB, BCL2, CDC25B, CDK6, CYP1A1, DRD3, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, TERT, TNKS |
3.86004 |
[BP] GO:0030003 |
cellular cation homeostasis
|
ABCG2, ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, GPR35, HTR2A, HTR2B, SMAD3 |
3.84262 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2, DRD3, HTR1A |
3.81446 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, DRD3, HTR2A |
3.80819 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
AURKB, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, HTR2A, IGF1R, INSR, MET, MMP12, PPARA, PTPN1, RORC, SMAD3, SRC, TERT, TNKS, TNKS2 |
3.80604 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, DRD1, EGFR, F10, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK, TNKS, TOP1 |
3.77623 |
[BP] GO:1904063 |
None
|
ADRA2A, DRD2, DRD3, GPR35, KCNH2, MMP9 |
3.74865 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.74865 |
[BP] GO:0006873 |
cellular ion homeostasis
|
ABCG2, ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, GPR35, HTR2A, HTR2B, SMAD3 |
3.74252 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
3.72955 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
3.72365 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, ADRA2A, CYP19A1, DRD2, DRD3, EGFR, HMGCR, HTR1A, HTR2A, HTR2B, MMP12, SLC6A4, SRC |
3.70962 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, ADRA2A, AURKB, CDC25B, DRD2, EGFR, FLT3, HTR2A, HTR2B, INSR, PTPN1, SRC, TEK, TNKS |
3.68911 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, ADRA2A, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, HMGCR, HTR2A, HTR2B, IGF1R, INSR, PTPN1, SRC |
3.67468 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SRC, TEK |
3.66567 |
[BP] GO:0010518 |
positive regulation of phospholipase activity
|
ADRA1A, EGFR, ESR1, HTR2A, HTR2B |
3.64511 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, ADRA2A, DUSP3, EGFR, FLT3, HMGCR, HTR2A, HTR2B, IGF1R, INSR, PTPN1, SRC |
3.63796 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, EGFR, ESR1, GPR35, HTR2A, HTR2B, SMAD3 |
3.61634 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADRA2A, AURKB, BCL2, CSNK2A1, CYP2D6, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HMGCR, HSPA1A, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, TERT, TNKS, TNKS2, XDH |
3.61054 |
[BP] GO:0009820 |
alkaloid metabolic process
|
CYP1A2, CYP2D6, CYP3A4 |
3.60694 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, ADRA2A, EGFR, FLT3, HTR2A, HTR2B, INSR, PTPN1, SRC |
3.59759 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
AURKB, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2A, HTR2B, IGF1R, INSR, MET, MMP12, PPARA, RORC, SMAD3, SRC, TERT, TNKS, TNKS2 |
3.59531 |
[BP] GO:0051098 |
regulation of binding
|
AURKB, BCL2, CYP2D6, MET, MMP9, PPARA, SMAD3, SRC, TERT, TNKS |
3.55392 |
[BP] GO:0019933 |
None
|
ADRA1A, ADRA2A, DRD1, DRD2, DRD3, HTR5A |
3.5483 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, GBA2 |
3.52575 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.5179 |
[BP] GO:0007202 |
None
|
ADRA1A, EGFR, HTR2A, HTR2B |
3.5179 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA1A, ADRA2A, CHRM2, DRD2, DRD3, EGFR, GPR35, HTR2A, KCNH2, SMAD3 |
3.51713 |
[BP] GO:0050890 |
None
|
ADORA1, DRD1, DRD2, DRD3, EGFR, HMGCR, HTR2A, INSR, SLC6A4 |
3.50575 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
AURKB, BCL2, DRD3, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.504 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, CYP1A1, CYP1B1, DRD1, EGFR, ESR1, FLT3, RORC, SLC6A4, SRC |
3.47825 |
[BP] GO:0034766 |
None
|
ADRA2A, DRD2, DRD3, GPR35, KCNH2, MMP9 |
3.47825 |
[BP] GO:0051726 |
regulation of cell cycle
|
AURKB, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, DRD2, DRD3, DUSP3, EGFR, HSPA1A, INSR, PIM1, SLC6A4, SMAD3, SRC, TERT, TNKS |
3.47755 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6 |
3.46229 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
AURKB, AXL, BCL2, DRD2, DRD3, ESR1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.45474 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, AURKB, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HMGCR, HSPA1A, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP1, XDH |
3.45113 |
[BP] GO:0003014 |
None
|
ADORA1, ADRA1A, AKR1B1, BCL2, DRD2, HSD11B2 |
3.43589 |
[BP] GO:0051940 |
None
|
DRD1, DRD2, DRD3 |
3.43589 |
[BP] GO:0051584 |
None
|
DRD1, DRD2, DRD3 |
3.43589 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, DRD3, HMGCR, PPARA, SMAD3, TEK |
3.43415 |
[BP] GO:0032922 |
None
|
DRD2, DRD3, PPARA, RORC, TOP1 |
3.43415 |
[BP] GO:0008217 |
None
|
ADORA1, ADRA1A, DRD2, DRD3, HSD11B2, PPARA, SMAD3 |
3.4167 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CDK6, CYP1B1, DRD1, EGFR, KCNH2, KDR, SRC |
3.40065 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, ADRA2A, CYP19A1, DRD2, DRD3, EGFR, HMGCR, HTR1A, HTR2A, HTR2B, MMP12, SLC6A4, SRC |
3.39834 |
[BP] GO:0043266 |
None
|
ADORA1, ADRA2A, DRD1, DRD2, HTR2A, KCNH2 |
3.39344 |
[BP] GO:0007610 |
None
|
BCL2, DRD1, DRD2, DRD3, EGFR, HMGCR, HTR1A, HTR2A, HTR2B, INSR, PPARA, SLC6A4 |
3.36967 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRA1A, ADRA2A, CHRM2, DRD2, EGFR, HTR2A, KCNH2 |
3.3692 |
[BP] GO:0019935 |
None
|
ADRA1A, ADRA2A, DRD1, DRD2, DRD3, HTR5A |
3.34823 |
[BP] GO:0034763 |
None
|
ADRA2A, DRD2, DRD3, GPR35, KCNH2, MMP9 |
3.34823 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, HTR2A, MET, SRC |
3.33018 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, HTR2A, MET, SRC |
3.33018 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, HTR2A, MET, SRC |
3.33018 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, HTR2A, MET, SRC |
3.33018 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6 |
3.3221 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, ADRA2A, CDC25B, DRD2, EGFR, FLT3, HTR2A, HTR2B, INSR, PTPN1, SRC, TEK |
3.31901 |
[BP] GO:0050793 |
regulation of developmental process
|
AXL, BCL2, CA2, CDK6, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, ESRRB, F3, HMGCR, HTR2A, INSR, KDR, NUAK1, PIM1, PPARA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TNKS2, XDH |
3.31334 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TERT, TNKS, TNKS2 |
3.30885 |
[BP] GO:0010517 |
regulation of phospholipase activity
|
ADRA1A, EGFR, ESR1, HTR2A, HTR2B |
3.30885 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, DRD2, EGFR, HTR2A |
3.30885 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA1A, ADRA2A, BCL2, CDC25B, DRD2, EGFR, FLT3, HMGCR, HTR2A, HTR2B, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH |
3.3066 |
[BP] GO:0071073 |
None
|
FABP3, HTR2A, HTR2B |
3.29723 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, CDK6, KDR, SMAD3, SRC, TEK |
3.29723 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AXL, CDK6, CYP1B1, DRD1, EGFR, ESR1, IGF1R, INSR, MMP2, MMP9, RORC, SLC6A4, SRC |
3.29715 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CES1, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.29539 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
ABCG2, ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, GPR35, HTR2A, HTR2B, SMAD3 |
3.27994 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CYP1A1, EGFR, ESR1, FLT3, HTR1A, MET, PIM1, SRC, TEK, TYR |
3.27657 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, GPR35, HTR2A, HTR2B, SMAD3 |
3.22633 |
[BP] GO:0060193 |
positive regulation of lipase activity
|
ADRA1A, EGFR, ESR1, HTR2A, HTR2B |
3.22195 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, EGFR, HTR2B, MMP12, SLC6A4, SRC |
3.21901 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
3.19427 |
[BP] GO:0035265 |
organ growth
|
ADRA1A, BCL2, CYP19A1, ESR1 |
3.19061 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK |
3.14914 |
[BP] GO:0032787 |
None
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, FABP3, GBA2, PPARA |
3.14914 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.14716 |
[BP] GO:1900542 |
None
|
ADRA2A, DRD1, DRD2, DRD3, ESRRB, HTR2A, INSR, PPARA |
3.13972 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2, HTR2A |
3.13972 |
[BP] GO:0045744 |
None
|
ADRA2A, DRD2, DRD3, MET |
3.13972 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, AXL, BCL2, CDC25B, CDK6, CES1, CYP1A1, DRD1, DRD2, EGFR, ESR1, ESRRB, FABP4, FLT3, FUT7, GBA2, HMGCR, HTR2B, KDR, MET, MMP2, MMP9, RORC, SMAD3, SRC, TEK, TERT |
3.1297 |
[BP] GO:0007611 |
None
|
DRD1, DRD2, DRD3, EGFR, HMGCR, HTR2A, INSR, SLC6A4 |
3.1297 |
[BP] GO:0055074 |
calcium ion homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, GPR35, HTR2A, HTR2B, SMAD3 |
3.12841 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, DRD2, EGFR, ESR1, FABP4, HSPA1A, MMP12, MMP2, PPARA, PTPN1, SMAD3, SRC, TEK |
3.11192 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
ABCG2, ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, GPR35, HTR2A, HTR2B, SMAD3 |
3.11137 |
[BP] GO:0051704 |
multi-organism process
|
AXL, BCL2, CDK6, CHRM2, CYP1A1, DRD3, EGFR, HSD11B2, HSPA1A, HTR2A, INSR, KDR, MET, MMP1, MMP12, SLC6A4, SMAD3, SRC, TOP1 |
3.11137 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
ADRA2A, AURKB, BCL2, CSNK2A1, CYP2D6, DRD2, DRD3, DUSP3, ESR1, ESR2, ESRRA, FABP4, HMGCR, HSPA1A, HTR2B, IGF1R, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, TERT, TNKS, TNKS2, XDH |
3.09894 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, DRD2, MMP12, PPARA, SMAD3, TEK |
3.09562 |
[BP] GO:0022029 |
None
|
DRD1, DRD2, EGFR, HTR6 |
3.09562 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, GPR35, HTR2A, HTR2B, SMAD3 |
3.09074 |
[BP] GO:0001503 |
ossification
|
ALPL, BCL2, EGFR, MMP2, MMP9, TEK |
3.08482 |
[BP] GO:0006140 |
None
|
ADRA2A, DRD1, DRD2, DRD3, ESRRB, HTR2A, INSR, PPARA |
3.06512 |
[BP] GO:0045913 |
None
|
ESRRB, HTR2A, INSR, PPARA, SRC |
3.05666 |
[BP] GO:0009605 |
response to external stimulus
|
ADORA1, ADRA1A, ALPL, AXL, BCL2, CDK6, CHRM2, CYP1A1, CYP1A2, DRD3, EGFR, HMGCR, HSD11B2, HTR2A, MMP12, SLC6A4, SMAD3, SRC, TYR |
3.05648 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, EGFR, MMP9, SRC |
3.05632 |
[BP] GO:0002031 |
None
|
DRD2, DRD3, HTR2B |
3.05632 |
[BP] GO:0010038 |
response to metal ion
|
BCL2, CA2, CYP1A1, CYP1A2, DRD2, EGFR, FABP4, MMP9, TERT |
3.05304 |
[BP] GO:0010907 |
None
|
ESRRB, INSR, PPARA, SRC |
3.05304 |
[BP] GO:0051051 |
negative regulation of transport
|
ADORA1, ADRA2A, BCL2, DRD2, DRD3, GPR35, HMGCR, HSPA1A, HTR2A, KCNH2, MMP9 |
3.03951 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, ADRA2A, BCL2, CSNK2A1, EGFR, ESRRB, HSPA1A, HTR2A, HTR2B, INSR, KDR, MET, PPARA, PTPN1, SMAD3 |
3.03951 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, ADRA1A, ADRA2A, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HMGCR, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
3.03484 |
[BP] GO:0023052 |
None
|
ADORA1, ADRA1A, CHRM2, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7, KCNH2, SLC6A2, TEK |
3.02355 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, HTR2A, MET |
3.01447 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, BCL2, CDK6, CYP1B1, DRD2, FABP3, HSPA1A, SLC6A4, SMAD3, TERT, XDH |
2.99329 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, AURKB, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, HMGCR, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP1, XDH |
2.98888 |
[BP] GO:0007189 |
None
|
ADRA1A, ADRA2A, DRD1, DRD2, DRD3 |
2.95041 |
[BP] GO:0050678 |
None
|
CDK6, EGFR, F3, HTR2B, KDR, MMP12, SMAD3, TEK, XDH |
2.95036 |
[BP] GO:0015872 |
None
|
DRD1, SLC6A2, SLC6A4 |
2.95036 |
[BP] GO:0042738 |
exogenous drug catabolic process
|
CYP1A2, CYP2C19, CYP3A4 |
2.95036 |
[BP] GO:0070989 |
oxidative demethylation
|
CYP1A2, CYP2D6, CYP3A4 |
2.95036 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, DRD2, DRD3, FABP3, PPARA |
2.93466 |
[BP] GO:0006807 |
nitrogen compound metabolic process
|
ABCG2, ACHE, AKR1B1, AKR1B10, ALPL, AOX1, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FLT3, FUT7, GBA2, HMGCR, HSPA1A, HTR1A, HTR2B, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
2.93418 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.93418 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, ADRA2A, CDC25B, DRD2, EGFR, FLT3, HTR2A, HTR2B, INSR, PTPN1, SRC |
2.91639 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, EGFR, ESR1, ESRRA, HTR5A, SLC6A4 |
2.90916 |
[BP] GO:0010564 |
regulation of cell cycle process
|
AURKB, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, DRD2, DRD3, EGFR, HSPA1A, INSR, TERT, TNKS |
2.90807 |
[BP] GO:0032413 |
None
|
ADRA2A, DRD2, DRD3, GPR35, MMP9 |
2.87986 |
[BP] GO:0032467 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.87764 |
[BP] GO:0016477 |
cell migration
|
AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, KDR, MMP1, MMP12, MMP9, SRC, TEK |
2.87328 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.8558 |
[BP] GO:0060134 |
None
|
DRD1, DRD2, DRD3 |
2.8558 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
ADRA1A, CA2, CA7 |
2.8558 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, HMGCR, MMP2, MMP9, TERT |
2.84215 |
[BP] GO:0007267 |
None
|
ADORA1, ADRA1A, CHRM2, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7, SLC6A2, TEK |
2.83719 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, ADRA2A, BCL2, EGFR, HTR2B, MET, PPARA, SMAD3 |
2.83719 |
[BP] GO:0046883 |
regulation of hormone secretion
|
ADORA1, ADRA2A, CYP19A1, DRD2, EGFR, HMGCR, HTR1A, HTR2A |
2.83719 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CYP1A1, EGFR, HMGCR, HSD11B2, SLC6A4, SRC, TYR |
2.83481 |
[BP] GO:0003012 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7, KCNH2 |
2.8276 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
2.7957 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, ADRA2A, EGFR, FLT3, HTR2A, HTR2B, INSR, PTPN1, SRC |
2.76971 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.7655 |
[BP] GO:0051580 |
None
|
DRD1, DRD2, DRD3 |
2.7655 |
[BP] GO:0051967 |
None
|
ADORA1, DRD2, HTR2A |
2.7655 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, DRD1, EGFR, ESR1, ESRRB, HSD11B2, HSD17B2, INSR, MMP2, MMP9, SLC6A4, SRC |
2.73773 |
[BP] GO:0010959 |
None
|
ADORA1, ADRA2A, BCL2, DRD1, DRD2, DRD3, GPR35, HTR2A, KCNH2 |
2.73773 |
[BP] GO:0007154 |
None
|
ADORA1, ADRA1A, AXL, BCL2, CHRM2, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7, SLC6A2, TEK |
2.70521 |
[BP] GO:0032410 |
None
|
ADRA2A, DRD2, DRD3, GPR35, MMP9 |
2.69245 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, ADRA2A, DRD2, DRD3, EGFR, HMGCR, HTR2B, MMP12, SRC |
2.68417 |
[BP] GO:0045776 |
None
|
ADORA1, DRD2, DRD3, PPARA |
2.68417 |
[BP] GO:0043268 |
None
|
ADORA1, ADRA2A, DRD1, KCNH2 |
2.68417 |
[BP] GO:0001963 |
None
|
DRD1, DRD2, DRD3 |
2.6816 |
[BP] GO:0051937 |
None
|
DRD1, SLC6A2, SLC6A4 |
2.6816 |
[BP] GO:0070198 |
None
|
TERT, TNKS, TNKS2 |
2.6816 |
[BP] GO:0040008 |
regulation of growth
|
BCL2, CSNK2A1, DRD2, DRD3, EGFR, ESR2, HSPA1A, INSR, PIM1, SLC6A4, SMAD3, TNKS2 |
2.6812 |
[BP] GO:0051781 |
None
|
AURKB, CDC25B, DRD2, DRD3, HTR2B |
2.6757 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT |
2.66508 |
[BP] GO:0060191 |
regulation of lipase activity
|
ADRA1A, EGFR, ESR1, HTR2A, HTR2B |
2.65606 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.65566 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.65566 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPL, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F10, F3, FLT3, FUT7, HTR2B, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1 |
2.62731 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
AURKB, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, IGF1R, INSR, KDR, MET, MMP12, PPARA, RORC, SMAD3, SRC, TERT, TNKS, TNKS2 |
2.62731 |
[BP] GO:0051480 |
regulation of cytosolic calcium ion concentration
|
ADRA1A, DRD1, DRD2, ESR1, GPR35, HTR2A, HTR2B, SMAD3 |
2.62416 |
[BP] GO:0009416 |
response to light stimulus
|
AURKB, BCL2, DRD1, DRD2, DRD3, EGFR, HMGCR, TYR |
2.62416 |
[BP] GO:0051302 |
None
|
AURKB, CDC25B, DRD2, DRD3, ESRRB, HTR2B |
2.61316 |
[BP] GO:0071071 |
None
|
FABP3, HTR2A, HTR2B |
2.61316 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.61316 |
[BP] GO:0070920 |
None
|
EGFR, ESR1, TERT |
2.61316 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
CDC25B, CYP1A1, DRD3, DUSP3, INSR, TERT |
2.59942 |
[BP] GO:0001954 |
positive regulation of cell-matrix adhesion
|
CDK6, KDR, SMAD3, TEK |
2.58988 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
AURKB, EGFR, IGF1R, INSR, SRC, TNKS, TNKS2 |
2.57805 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HMGCR, HSPA1A, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
2.57805 |
[BP] GO:2001023 |
None
|
DRD1, DRD2, DRD3, HTR2A, MET |
2.57805 |
[BP] GO:0006936 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7, KCNH2 |
2.56792 |
[BP] GO:0019725 |
cellular homeostasis
|
ABCG2, ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, GPR35, HTR2A, HTR2B, SMAD3 |
2.56484 |
[BP] GO:0007268 |
None
|
CHRM2, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7, SLC6A2 |
2.56484 |
[BP] GO:0098916 |
None
|
CHRM2, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7, SLC6A2 |
2.56484 |
[BP] GO:0051588 |
None
|
DRD1, DRD2, DRD3, HTR1A, SLC6A4 |
2.55965 |
[BP] GO:0040011 |
locomotion
|
AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, KDR, MET, MMP1, MMP12, MMP9, SRC, TEK |
2.55736 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.54201 |
[BP] GO:0009822 |
alkaloid catabolic process
|
CYP2D6, CYP3A4 |
2.53394 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.53394 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.53394 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.53394 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
ADRA2A, AKR1B1, DRD1, EGFR, ESR1, FLT3, IGF1R, INSR, MMP2, SLC6A4, SMAD3, SRC |
2.53311 |
[BP] GO:0050433 |
None
|
ADRA2A, DRD2, DRD3, HTR2A |
2.53311 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, EGFR, FLT3, HSD11B2, SRC |
2.52004 |
[BP] GO:0099536 |
None
|
CHRM2, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7, SLC6A2 |
2.50728 |
[BP] GO:0099537 |
None
|
CHRM2, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7, SLC6A2 |
2.50728 |
[BP] GO:0008542 |
None
|
DRD1, DRD2, DRD3, HMGCR |
2.50183 |
[BP] GO:0048870 |
cell motility
|
AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, KDR, MMP1, MMP12, MMP9, SRC, TEK |
2.50183 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.48129 |
[BP] GO:0045821 |
None
|
ESRRB, HTR2A, INSR |
2.48129 |
[BP] GO:0014821 |
None
|
DRD1, DRD2, HTR2B |
2.48129 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, ADRA1A, ADRA2A, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HMGCR, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
2.48069 |
[BP] GO:0006811 |
None
|
ADRA1A, CA1, CA12, CA14, CA2, CA4, CA7, DRD1, DRD2, DRD3, FABP3, HTR2A, HTR2B, KCNH2, PPARA, SLC6A2, SLC6A4 |
2.47336 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MMP9, PTPN1, SRC |
2.46911 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, EGFR, FLT3, HSD11B2, SRC |
2.45312 |
[BP] GO:0010906 |
None
|
ESRRB, INSR, PPARA, RORC, SRC |
2.44927 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, ADRA2A, CA2, DRD2, DRD3, EGFR, HMGCR, HTR2B, MMP12, PTPN1, SMAD3, SRC |
2.44827 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.41636 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.41636 |
[BP] GO:0051197 |
None
|
ESRRB, HTR2A, INSR |
2.41636 |
[BP] GO:0042752 |
None
|
ADORA1, DRD2, DRD3, PPARA, RORC |
2.41121 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AXL, BCL2, CDC25B, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, INSR, SRC |
2.40355 |
[BP] GO:0050730 |
None
|
ADORA1, ADRA2A, EGFR, FLT3, HTR2A, PTPN1, SRC |
2.39414 |
[BP] GO:0007568 |
aging
|
ADRA1A, AURKB, BCL2, CYP1A1, HMGCR, HTR2A, TERT |
2.39414 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.38602 |
[BP] GO:0010676 |
None
|
ESRRB, INSR, PPARA, SRC |
2.38156 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6 |
2.37494 |
[BP] GO:0051172 |
None
|
ADRA2A, AURKB, CSNK2A1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HMGCR, HSPA1A, IGF1R, MMP12, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, TERT, TNKS, TNKS2, XDH |
2.37187 |
[BP] GO:0031667 |
response to nutrient levels
|
ALPL, BCL2, CYP1A1, EGFR, HMGCR, HSD11B2, SLC6A4, SRC, TYR |
2.37126 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, CES1, CYP19A1, CYP3A4, HMGCR, TYR |
2.36077 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.35978 |
[BP] GO:0071880 |
None
|
ADRA1A, ADRA2A, DRD2 |
2.35978 |
[BP] GO:0007632 |
None
|
DRD1, DRD2, DRD3, HMGCR |
2.35789 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.35789 |
[BP] GO:2000026 |
regulation of multicellular organismal development
|
AXL, BCL2, CA2, CDK6, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, F3, HMGCR, INSR, KDR, PIM1, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
2.35364 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.34392 |
[BP] GO:0006464 |
cellular protein modification process
|
ALPL, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, HTR2B, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIM1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1 |
2.34169 |
[BP] GO:0036211 |
protein modification process
|
ALPL, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, HTR2B, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIM1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1 |
2.34169 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, AXL, BCL2, CA1, CSNK2A1, DRD2, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.34143 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.33296 |
[BP] GO:0033555 |
multicellular organismal response to stress
|
BCL2, DRD1, HTR1A, SLC6A2 |
2.33296 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.33296 |
[BP] GO:0018105 |
peptidyl-serine phosphorylation
|
AURKB, BCL2, DRD1, SRC, TNKS, TOP1 |
2.33011 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, SLC6A4, SRC |
2.32037 |
[BP] GO:0044267 |
cellular protein metabolic process
|
ALPL, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, HTR2B, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP2, NUAK1, PIM1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1 |
2.31141 |
[BP] GO:0015844 |
None
|
DRD1, SLC6A2, SLC6A4 |
2.30733 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.30733 |
[BP] GO:0031623 |
None
|
ACHE, DRD2, DRD3, HTR2B |
2.30684 |
[BP] GO:0006082 |
organic acid metabolic process
|
ABCG2, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, FABP3, GBA2, PIM1, PPARA, TYR |
2.30557 |
[BP] GO:0007613 |
None
|
DRD1, DRD2, HTR2A, INSR, SLC6A4 |
2.29648 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HMGCR, HSPA1A, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
2.29491 |
[BP] GO:0048732 |
gland development
|
BCL2, CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, TYR |
2.29466 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.28861 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.28861 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.28861 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, EGFR, INSR, SMAD3, XDH |
2.2875 |
[BP] GO:0046686 |
response to cadmium ion
|
CYP1A2, EGFR, MMP9, TERT |
2.28716 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AURKB, BCL2, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HMGCR, HSPA1A, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
2.2766 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.2611 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.2611 |
[BP] GO:0051194 |
None
|
ESRRB, HTR2A, INSR |
2.2611 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.2611 |
[BP] GO:0050708 |
None
|
ACHE, ADRA2A, DRD2, DRD3, EGFR, HMGCR, HTR2B, MMP12, SRC |
2.25515 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.25469 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, FABP3, GBA2, PIM1, PPARA, TYR |
2.25204 |
[BP] GO:0007204 |
positive regulation of cytosolic calcium ion concentration
|
ADRA1A, DRD1, DRD2, ESR1, GPR35, HTR2A, HTR2B |
2.24467 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, ADRA2A, FLT3, HTR2A, PTPN1, SRC |
2.24185 |
[BP] GO:0006109 |
regulation of carbohydrate metabolic process
|
ESRRB, HTR2A, INSR, PPARA, RORC, SRC |
2.229 |
[BP] GO:0050679 |
None
|
EGFR, F3, HTR2B, KDR, MMP12, TEK |
2.21624 |
[BP] GO:0070988 |
demethylation
|
CYP1A1, CYP1A2, CYP2D6, CYP3A4 |
2.21165 |
[BP] GO:0051953 |
None
|
ADORA1, ADRA2A, DRD2 |
2.21165 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.21165 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.21165 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.18649 |
[BP] GO:0019229 |
None
|
ADRA1A, ADRA2A, EGFR, HTR2A |
2.18649 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, DRD2, EGFR, HTR2B, MMP12, SRC |
2.17907 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, AXL, BCL2, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
2.16454 |
[BP] GO:0051094 |
positive regulation of developmental process
|
AXL, BCL2, CA2, CYP1B1, DRD2, ESRRB, F3, HMGCR, HTR2A, INSR, KDR, PIM1, SMAD3, SRC, TEK, TERT |
2.16231 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.16231 |
[BP] GO:0071875 |
None
|
ADRA1A, ADRA2A, DRD2 |
2.16231 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.16231 |
[BP] GO:0042737 |
drug catabolic process
|
ACHE, CYP1A2, CYP2C19, CYP2D6, CYP3A4 |
2.15985 |
[BP] GO:0034762 |
None
|
ADRA2A, BCL2, CA2, DRD1, DRD2, DRD3, GPR35, KCNH2, MMP9 |
2.15985 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
CDK6, DUSP3, EGFR, HMGCR, HSPA1A, IGF1R, MET, NUAK1, PTPN1, TERT, XDH |
2.15766 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, PPARA, SMAD3, TEK |
2.14594 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, DRD2, DRD3, FABP3, PPARA |
2.1384 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, FABP3, HSD11B2, IGF1R, INSR, PPARA, SRC, TEK |
2.12277 |
[BP] GO:0009896 |
positive regulation of catabolic process
|
ADRA2A, CSNK2A1, ESRRB, HSPA1A, HTR2A, INSR, KDR, PPARA, PTPN1 |
2.12145 |
[BP] GO:0046888 |
None
|
ADORA1, ADRA2A, DRD2, HMGCR |
2.11922 |
[BP] GO:0018209 |
peptidyl-serine modification
|
AURKB, BCL2, DRD1, SRC, TNKS, TOP1 |
2.11922 |
[BP] GO:0050927 |
None
|
F3, KDR, SMAD3 |
2.11922 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.11112 |
[BP] GO:0043696 |
None
|
CDK6, ESRRB |
2.11112 |
[BP] GO:0043697 |
None
|
CDK6, ESRRB |
2.11112 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.11112 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.11112 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.11112 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.11112 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.11112 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B |
2.11112 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.10621 |
[BP] GO:0060402 |
None
|
ADRA1A, DRD2, HTR2A, HTR2B |
2.10621 |
[BP] GO:0008150 |
biological_process
|
ABCG2, ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CDC25B, CDK6, CES1, CES2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GPR35, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SIGMAR1, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
2.10621 |
[BP] GO:1903532 |
None
|
ACHE, CYP19A1, DRD2, EGFR, HTR2B, MMP12, SLC6A4, SRC |
2.08921 |
[BP] GO:0071396 |
cellular response to lipid
|
AXL, CDK6, EGFR, ESR1, FLT3, RORC, SLC6A4, SRC |
2.08921 |
[BP] GO:0010810 |
regulation of cell-substrate adhesion
|
BCL2, CDK6, KDR, SMAD3, SRC, TEK |
2.08921 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.08921 |
[BP] GO:0050926 |
None
|
F3, KDR, SMAD3 |
2.08921 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.08921 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.08921 |
[BP] GO:0001975 |
None
|
DRD1, DRD2, DRD3 |
2.08921 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.08921 |
[BP] GO:0006940 |
None
|
ADORA1, ADRA1A, ADRA2A, CHRM2 |
2.08921 |
[BP] GO:0051926 |
negative regulation of calcium ion transport
|
ADRA2A, BCL2, DRD2, GPR35 |
2.08921 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, ADRA2A, BCL2, CSNK2A1, DRD2, DRD3, EGFR, HMGCR, HTR2B, MMP12, PTPN1, SMAD3, SRC, TERT |
2.08548 |
[BP] GO:0045934 |
None
|
ADRA2A, AURKB, DRD2, DRD3, ESR1, ESR2, ESRRA, FABP4, HSPA1A, MMP12, PPARA, RORC, SMAD3, SRC, TERT, TNKS, TNKS2 |
2.0813 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, AURKB, AXL, BCL2, CA1, CA2, CA7, CDC25B, CDK6, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GPR35, HMGCR, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SIGMAR1, SLC6A4, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
2.07471 |
[BP] GO:0010675 |
None
|
ESRRB, INSR, PPARA, RORC, SRC |
2.07471 |
[BP] GO:0048608 |
reproductive structure development
|
AXL, BCL2, CYP19A1, ESR1, HSD17B2, INSR, SRC |
2.06845 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.04564 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
BCL2, DRD2, DRD3, TNKS2 |
2.04564 |
[BP] GO:0006110 |
None
|
ESRRB, HTR2A, INSR, PPARA |
2.04564 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, FABP3, PPARA |
2.04564 |
[BP] GO:0007584 |
response to nutrient
|
ALPL, CYP1A1, EGFR, HMGCR, SLC6A4, TYR |
2.03733 |
[BP] GO:0090068 |
positive regulation of cell cycle process
|
AURKB, CDC25B, CYP1A1, DRD2, DRD3, INSR, TERT |
2.03395 |
[BP] GO:0032465 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.02299 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, SRC, TEK |
2.01563 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, HSD11B2, HSPA1A, HTR1A, MMP2, MMP9, NUAK1, PPARA, PTPN1, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT |
2.01037 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, DRD3 |
2.00561 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, CYP3A4, ESR1 |
2.00561 |
[BP] GO:0014059 |
None
|
DRD2, DRD3, HTR2A |
2.00561 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, HMGCR |
2.00358 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AXL, CA4, CHRM2, DRD1, DRD2, DRD3, F10, F3, FLT3, GPR35, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, SIGMAR1, SLC6A2, SLC6A4, TEK |
7.837 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AXL, CHRM2, DRD1, DRD2, DRD3, FLT3, GPR35, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, SIGMAR1, SLC6A2, SLC6A4, TEK |
6.35273 |
[CC] GO:0044459 |
plasma membrane part
|
ABCG2, ADORA1, ADORA3, ADRA1A, ADRA2A, AXL, CA2, CA4, CHRM2, DRD1, DRD2, DRD3, DUSP3, EGFR, F10, F3, FLT3, GPR35, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KCNH2, KDR, MET, SIGMAR1, SLC6A2, SLC6A4, SRC, TEK |
5.96226 |
[CC] GO:0016020 |
membrane
|
ABCG2, ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, ALOX5, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, EGFR, ESR1, F10, F3, FLT3, FUT7, GBA2, GPR35, HMGCR, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KCNH2, KDR, MET, MMP2, PIM1, PTPN1, SIGMAR1, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TYR |
5.7684 |
[CC] GO:0005886 |
plasma membrane
|
ABCG2, ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, ALPL, AXL, CA12, CA14, CA2, CA4, CHRM2, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ESR1, F10, F3, FLT3, GBA2, GPR35, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KCNH2, KDR, MET, MMP2, PIM1, PTPN1, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT |
5.46296 |
[CC] GO:0044425 |
membrane part
|
ABCG2, ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, F10, F3, FLT3, FUT7, GBA2, GPR35, HMGCR, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KCNH2, KDR, MET, PTPN1, SIGMAR1, SLC6A2, SLC6A4, SRC, TEK, TYR |
4.89569 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
BCL2, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DRD1, EGFR, F10, FLT3, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B2, PTPN1, SIGMAR1 |
4.56177 |
[CC] GO:0044444 |
cytoplasmic part
|
ABCG2, ACHE, ADORA1, ADRA1A, AKR1B1, AKR1B10, ALOX5, AOX1, AURKB, BCL2, CA1, CA2, CA4, CA7, CDC25B, CDK6, CES1, CES2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, FABP3, FABP4, FLT3, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR2A, HTR5A, INSR, KCNH2, KDR, MMP2, MMP9, PIM1, PTPN1, SIGMAR1, SLC6A4, SMAD3, SRC, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
3.66221 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DRD1, EGFR, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B2, SIGMAR1 |
3.55542 |
[CC] GO:0005783 |
None
|
ADORA1, BCL2, CA4, CES1, CES2, CYP19A1, CYP2D6, FLT3, GBA2, HMGCR, HSPA1A, HTR5A, KDR, PTPN1, SIGMAR1, XDH |
3.44147 |
[CC] GO:0045121 |
membrane raft
|
ADRA1A, EGFR, HTR2A, INSR, KDR, SLC6A2, SLC6A4, SRC, TEK |
3.29723 |
[CC] GO:0098857 |
membrane microdomain
|
ADRA1A, EGFR, HTR2A, INSR, KDR, SLC6A2, SLC6A4, SRC, TEK |
3.27994 |
[CC] GO:0098590 |
plasma membrane region
|
ABCG2, ADORA1, ADRA1A, ADRA2A, CA2, CA4, CHRM2, DRD1, DRD2, EGFR, HTR2A, INSR, MET, SIGMAR1, SRC, TEK |
3.27912 |
[CC] GO:0031224 |
None
|
ABCG2, ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, ALPL, AXL, CA12, CA14, CA4, CHRM2, CYP3A4, DRD1, DRD2, DRD3, EGFR, ESR1, F10, F3, FLT3, FUT7, GBA2, GPR35, HMGCR, HSD11B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, SIGMAR1, SLC6A2, SLC6A4, TEK, TYR |
2.77394 |
[CC] GO:0098589 |
membrane region
|
ADRA1A, EGFR, HTR2A, INSR, KDR, SLC6A2, SLC6A4, SRC, TEK |
2.74515 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ABCG2, ACHE, ADORA1, ADRA1A, AKR1B1, AKR1B10, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA2, CA4, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HMGCR, HSPA1A, HTR2A, HTR5A, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SIGMAR1, SMAD3, SRC, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
2.67563 |
[CC] GO:0044464 |
cell part
|
ABCG2, ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CDC25B, CDK6, CES1, CES2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GPR35, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KCNH2, KDR, MET, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SIGMAR1, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
2.67388 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.35978 |
[CC] GO:0031090 |
None
|
ABCG2, ADRA1A, ALOX5, BCL2, CA4, CHRM2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DRD1, DRD2, EGFR, FUT7, GBA2, HMGCR, INSR, SIGMAR1, SLC6A4, SMAD3, SRC, TNKS, TNKS2, TYR |
2.20503 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, ADRA2A, CA2, CA4, EGFR, TEK |
2.10621 |
[CC] GO:0016021 |
None
|
ABCG2, ADORA1, ADORA3, ADRA1A, ADRA2A, ALPL, AXL, CA12, CA14, CHRM2, CYP3A4, DRD1, DRD2, DRD3, EGFR, ESR1, F3, FLT3, FUT7, GBA2, GPR35, HMGCR, HSD11B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, SIGMAR1, SLC6A2, SLC6A4, TEK, TYR |
2.07471 |
[MF] GO:0043167 |
ion binding
|
ABCG2, ACHE, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
13.016 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SMAD3, TNKS, TYR, XDH |
12.2367 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AXL, CHRM2, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KCNH2, KDR, MET, PPARA, RORC, SIGMAR1, TEK |
11.172 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AXL, CDK6, CHRM2, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KCNH2, KDR, MET, PPARA, RORC, SIGMAR1, TEK |
10.366 |
[MF] GO:0008144 |
drug binding
|
ABCG2, ACHE, AURKB, AXL, CDK6, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, EGFR, FLT3, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, SIGMAR1, SLC6A4, SRC, TEK, TOP1 |
10.3036 |
[MF] GO:0008227 |
None
|
ADRA1A, ADRA2A, CHRM2, DRD2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
10.0227 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AXL, CHRM2, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KCNH2, KDR, MET, PPARA, RORC, SIGMAR1, TEK |
10.0227 |
[MF] GO:0003824 |
catalytic activity
|
ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DUSP3, EGFR, F10, F3, FLT3, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PTPN1, SRC, TEK, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
9.97593 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AXL, CHRM2, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KCNH2, KDR, MET, PPARA, RORC, SIGMAR1, SMAD3, TEK |
9.77202 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, SLC6A4 |
9.11847 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, TERT, TNKS, TNKS2, TYR, XDH |
8.00625 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
7.79097 |
[MF] GO:0030594 |
None
|
CHRM2, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.57485 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AXL, CHRM2, DRD1, DRD2, DRD3, EGFR, F3, FLT3, GPR35, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, SIGMAR1, TEK |
7.18147 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AXL, CHRM2, DRD1, DRD2, DRD3, EGFR, F3, FLT3, GPR35, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, SIGMAR1, TEK |
7.18147 |
[MF] GO:0099528 |
None
|
CHRM2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.9324 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.92516 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
6.67798 |
[MF] GO:0043176 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.6504 |
[MF] GO:0051378 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.6504 |
[MF] GO:0004993 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.59899 |
[MF] GO:0099589 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.59899 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4 |
6.50574 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
6.43039 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.27782 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, XDH |
6.23832 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
6.14274 |
[MF] GO:0005496 |
steroid binding
|
CYP3A4, ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1, RORC |
6.0392 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
5.7521 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, TYR |
5.74819 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, SMAD3, TNKS |
5.50829 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1 |
5.29427 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, ADRA2A, CSNK2A1, EGFR, ESRRB, FLT3, HTR2A, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SLC6A4, SMAD3, SRC |
4.99533 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.95387 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.95387 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, ADRA2A, EGFR, ESRRB, FLT3, HTR2A, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SMAD3, SRC |
4.94425 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, SRC |
4.83466 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
4.8148 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
4.7892 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
4.67998 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, SRC |
4.60846 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, HMGCR, HSD11B2, HSD17B1, SRC, XDH |
4.51438 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.51269 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ABCG2, ADORA1, ADRA2A, AOX1, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HMGCR, HSD11B2, HSD17B1, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TOP1, XDH |
4.34782 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2C19, CYP2D6, CYP3A4 |
4.34213 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1 |
4.3332 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, TYR |
4.27179 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
3.97132 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.97032 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, TERT, TNKS, TNKS2, TYR, XDH |
3.93738 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1 |
3.89547 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, ADRA1A, ADRA2A, CHRM2, DRD1, DRD2, DRD3, GPR35, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1 |
3.81446 |
[MF] GO:1901338 |
None
|
ADRA2A, DRD1, DRD2, DRD3 |
3.80819 |
[MF] GO:0008289 |
lipid binding
|
AXL, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, HSD11B2, HSD17B1, PPARA, RORC |
3.74771 |
[MF] GO:0042802 |
identical protein binding
|
ABCG2, ACHE, ADRA2A, AOX1, BCL2, CSNK2A1, DRD2, EGFR, ESR1, ESR2, FLT3, HMGCR, IGF1R, KCNH2, KDR, MET, MMP9, SLC6A4, SMAD3, TERT, TYR, XDH |
3.66221 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIM1, SRC, TEK, TERT, TOP1 |
3.65925 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.33952 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.29723 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.29723 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.24222 |
[MF] GO:0019899 |
enzyme binding
|
ADRA2A, AURKB, BCL2, CDC25B, CYP1A1, CYP1A2, CYP2C19, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRB, F3, HMGCR, HSPA1A, KCNH2, MET, PPARA, PTPN1, SLC6A4, SMAD3, SRC, TEK, TNKS2 |
3.21668 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, EGFR, HMGCR, MET, PPARA, PTPN1, SMAD3 |
3.19342 |
[MF] GO:0046983 |
protein dimerization activity
|
ABCG2, ACHE, ADORA1, ADRA1A, ADRA2A, AOX1, AXL, BCL2, DRD2, EGFR, FLT3, HMGCR, KCNH2, SLC6A4, SMAD3, TERT, TYR, XDH |
3.11354 |
[MF] GO:0042803 |
protein homodimerization activity
|
ABCG2, ACHE, ADRA2A, AOX1, BCL2, DRD2, FLT3, HMGCR, KCNH2, SLC6A4, SMAD3, TERT, TYR, XDH |
3.08482 |
[MF] GO:0004952 |
None
|
DRD1, DRD2, DRD3 |
2.95036 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.93418 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.93418 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ABCG2, ADORA1, AOX1, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HMGCR, HSD11B2, HSD17B1, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TOP1, XDH |
2.87636 |
[MF] GO:0035240 |
None
|
DRD1, DRD2, DRD3 |
2.8558 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, HSD17B1, IGF1R, INSR |
2.65606 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, CDC25B, CDK6, CSNK2A1, DUSP3, EGFR, F10, F3, FLT3, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PTPN1, SRC, TEK, TOP1 |
2.63404 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.62183 |
[MF] GO:0004935 |
None
|
ADRA1A, ADRA2A, DRD2 |
2.61316 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.53394 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A4 |
2.53394 |
[MF] GO:0047374 |
None
|
CES1, CES2 |
2.53394 |
[MF] GO:0036094 |
small molecule binding
|
ABCG2, ADORA1, AOX1, AURKB, AXL, CDK6, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HMGCR, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1, XDH |
2.50728 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.35978 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.28861 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.28861 |
[MF] GO:0032795 |
None
|
ADORA1, ADRA2A |
2.28861 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.28861 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.25469 |
[MF] GO:0000166 |
nucleotide binding
|
ABCG2, AOX1, AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, HMGCR, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1, XDH |
2.14694 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
ABCG2, AOX1, AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, HMGCR, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1, XDH |
2.14594 |
[MF] GO:0005518 |
collagen binding
|
ACHE, MMP12, MMP9, SMAD3 |
2.11922 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
2.11922 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.11112 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.11112 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.11112 |
[MF] GO:0019903 |
protein phosphatase binding
|
BCL2, EGFR, HMGCR, MET, PTPN1 |
2.10989 |
[MF] GO:0003674 |
molecular_function
|
ABCG2, ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CDC25B, CDK6, CES1, CES2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GPR35, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SIGMAR1, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
2.09412 |
[MF] GO:0051721 |
None
|
BCL2, HMGCR, PTPN1 |
2.00561 |